NovaBridge Biosciences
Uli
late-line treatment of non-small cell lung cancer
Resolved
98days ago
Catalyst readout · ~ Mar 31, 2026 estimated
What's at stake
A key catalyst for Uli (late-line treatment of non-small cell lung cancer) is expected ~ Mar 31, 2026.
Primary source
· SEC 6-K
verified 15h ago
“PFS data from Phase 1b/2 study for late-line treatment of NSCLC in combo with PD-(L)1 ± chemo”